Cencora (NYSE:COR - Get Free Report) had its price target hoisted by Barclays from $350.00 to $415.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has an "overweight" rating on the stock. Barclays's price target points to a potential upside of 18.52% from the company's current price.
Several other research analysts have also weighed in on COR. Wells Fargo & Company upped their target price on shares of Cencora from $395.00 to $400.00 and gave the stock an "overweight" rating in a research report on Tuesday. Wall Street Zen upgraded shares of Cencora from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Bank of America boosted their price target on Cencora from $285.00 to $310.00 in a research note on Tuesday, July 21st. Weiss Ratings upgraded Cencora from a "buy (b-)" rating to a "buy (b)" rating in a report on Tuesday, October 6th. Finally, JPMorgan Chase & Co. upped their price target on Cencora from $390.00 to $413.00 and gave the stock an "overweight" rating in a report on Tuesday, November 10th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $381.00.
Check Out Our Latest Stock Analysis on Cencora
Cencora Price Performance
Cencora stock opened at $350.14 on Wednesday. The company has a market cap of $66.82 billion, a P/E ratio of 19.54, a price-to-earnings-growth ratio of 1.85 and a beta of 0.58. Cencora has a one year low of $244.82 and a one year high of $377.54. The business has a fifty day moving average of $328.17 and a two-hundred day moving average of $317.23. The company has a debt-to-equity ratio of 3.01, a quick ratio of 0.59 and a current ratio of 0.94.
Cencora (NYSE:COR - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $4.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.58 by $0.08. Cencora had a net margin of 1.03% and a return on equity of 110.72%. The business had revenue of $88.35 billion during the quarter, compared to the consensus estimate of $87.95 billion. During the same quarter last year, the firm posted $3.84 EPS. The business's revenue was up 5.5% compared to the same quarter last year. As a group, analysts predict that Cencora will post 19.58 earnings per share for the current fiscal year.
Insider Activity at Cencora
In other news, EVP Elizabeth Campbell sold 11,300 shares of the firm's stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the completion of the transaction, the executive vice president directly owned 19,455 shares of the company's stock, valued at $6,305,754.60. This trade represents a 36.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.38% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Cencora
Several hedge funds have recently bought and sold shares of the stock. Mayflower Financial Advisors LLC increased its position in shares of Cencora by 1.1% during the third quarter. Mayflower Financial Advisors LLC now owns 2,829 shares of the company's stock valued at $849,000 after buying an additional 32 shares during the period. Alteri Wealth LLC grew its stake in Cencora by 2.2% during the third quarter. Alteri Wealth LLC now owns 1,575 shares of the company's stock valued at $473,000 after acquiring an additional 34 shares in the last quarter. William Blair Investment Management LLC grew its stake in Cencora by 1.3% during the third quarter. William Blair Investment Management LLC now owns 2,810 shares of the company's stock valued at $844,000 after acquiring an additional 35 shares in the last quarter. Pinnacle Associates Ltd. increased its holdings in Cencora by 1.8% during the 3rd quarter. Pinnacle Associates Ltd. now owns 2,203 shares of the company's stock worth $662,000 after acquiring an additional 38 shares during the period. Finally, Elmwood Wealth Management Inc. increased its holdings in Cencora by 0.9% during the 2nd quarter. Elmwood Wealth Management Inc. now owns 4,314 shares of the company's stock worth $1,221,000 after acquiring an additional 40 shares during the period. Hedge funds and other institutional investors own 97.52% of the company's stock.
Cencora Company Profile
(
Get Free Report)
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cencora, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cencora wasn't on the list.
While Cencora currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.